BBCR provides expert development guidance for Orphan Disease. The BBCR mission is to customize strategies, simplify clinical research, design cost-effective trials, streamline protocols, and create a regulatory roadmap.

As one of the first consultancy teams to streamline clinical trials, BBCR’s boutique consulting team specializes in rare disease and orphan indications dedicated to supporting pharmaceutical innovators, and nurturing each product’s strengths.

• The BBCR Team provides knowledge in cell, biologics and gene therapies
• BBCR addresses sponsors’ questions in the ever-changing regulatory environment
• Clinical strategy for orphan diseases and precision medicine
• RWE can be used to build orphan diseases evidence to support regulatory decisions
• BBCR serves small and medium sized biotech companies,venture capitalists and investors

Learn More at BBCR.com

Specializing in rare disease, Boston Biotech Clinical Research works with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process. Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements.

"*" indicates required fields

NAME:*

EMAIL:*

PHONE NUMBER:

COMMENTS:*

CAPTCHA

Comments

This field is for validation purposes and should be left unchanged.